SUMMARY Liver ultrasound was prospectively evaluated in 104 subjects who underwent liver biopsy, including 24 patients without evidence of liver disease (controls), and 80 with a broad spectrum of liver pathology. Ultrasonography was very specific (100%) and moderately sensitive (70%) in the detection of liver pathology, and hepatic neoplasms, steatosis, and fibrosis were detected by ultrasound in 80%, 80%, and 67% of cases respectively. In addition, ultrasonography diagnosed other pathologies-mainly biliary tract disease and abdominal neoplasms-in 26% of the patients.
Ultrasound is an 'effective regional-imaging device based on morphology'.' Gray-scale signal processing allows a detailed analysis of texture patterns of solid organs and thus the characterisation of both diffuse pathological processes and space-occupying lesions.
The contours and the echotexture of internal organs are outlined and changes in adjacent viscera delineated. Real-time imaging decreases examination time, and allows a quick and complete survey of the region of interest.
Liver ultrasound thus has the ability to detect diffuse as well as focal liver disease by analysis of the liver texture and may define associated abnormalities such as ascites or splenomegaly. Different patterns of metastatic liver disease have been described23 and an accuracy of 90 % has been claimed.4 Diffuse hepatocellular disease may produce changes in liver echo pattern and an accuracy of 81 % has been recorded in a retrospective study.5
In order to evaluate the accuracy, sensitivity, and specificity of liver ultrasound, a prospective study was undertaken of patients undergoing liver biopsy for evaluation of liver disease and controls undergoing abdominal surgery for various reasons.
Methods

PATIENTS
A careful ultrasonographic examination of the liver was performed in 110 consecutive patients before *Address for correspondence and reprint requesis: Dr J C Debongnie, D6partement de M6decine Interne, Clinique Ottignies, Belgium.
Received for publication 5 September 1980. liver biopsy between November 1978 and October 1979. All patients with obstructive jaundice or previously diagnosed liver disease were excluded.
Six patients were excluded: in four patients the liver biopsy was inadequate, including less than three portal spaces; and in two patients with probable liver tumour a final diagnosis was not reached as surgical biopsy was not performed after a negative peritoneoscopy.
In 85 patients, the liver biopsy was performed because a liver problem was suspected. Five had a normal liver on biopsy. In 22 patients with a presumed normal liver, including 12 patients with an intra-abdominal neoplasm and seven with benign conditions, all requiring surgery, a liver biopsy was obtained during laparotomy. All gave informed consent concerning the liver biopsy. Three of those 22 patients had an abnormal liver on biopsy (two neoplasms, one cirrhosis).
All patients undergoing liver ultrasonography and liver biopsy had a full clinical examination by the same examiner (JCD) and the following blood tests: haemogram, transaminases, alkaline phosphatase, gamma-glutamyl transferase, bilirubin, prothrombin time, serum electrophoresis. Nine patients had ascites, eight a clinically enlarged spleen, and 12 jaundice. Serum albumin was less than 3 g/l in seven patients, prothrombin time was below 50 % in two.
LIVER ULTRASONOGRAPHY Sonograms were obtained using two commercially available gray scale ultrasonoscopes.
A rapid real time abdominal survey (Toshiba Sonolayer-graph real-time unit using an electronic-Prospective study of liver ultrasound 'vascular' lesions (central vein dilatation, centrolobular necrosis), and pericardial effusion and dilatation of the hepatic veins and inferior vena cava were observed by ultrasound in one patient. Three patients with an amoebic abscess and one patient with a liver cyst were correctly diagnosed by ultrasound. In one patient with a drug-induced cholestatic jaundice, the liver was considered normal.
ACCURACY OF ULTRASONIC TISSUE DIAGNOSIS
The presence of liver cell necrosis, tumour, steatosis, and fibrosis was recorded separately for each patient and its detection rate by ultrasound is summarised in Table 2 . For example, a final diagnosis of alcoholic hepatitis may include liver cell necrosis, steatosis, and fibrosis. When present, tumour was diagnosed by ultrasound in 80 % of the patients, fat in 80 %, fibrosis (including cirrhosis) in 67%, and liver cell necrosis in 0%. In two patients with pure steatosis, ultrasound suggested additional fibrosis. In one cirrhotic patient, ultrasound falsely diagnosed steatosis. In those three patients, ultrasound was thus abnormal but gave an incorrect interpretation.
INTRAOBSERVER VARIATION OF READING
Photographic records of the ultrasound study were read blindly after completion of the study by the same radiologist and reported as normal or abnormal. Satisfactory records were available for 77 cases. All controls (n= 16) were classified as normal and 52 of the patients with liver disease (n=61) were considered as abnormal. At the first reading, 49 of the same patients were considered abnormal. In seven patients, a discrepancy was observed between the 
Discussion
In assessing the efficacy of a diagnostic test, interpretation of the results and establishment of the actual diagnosis should be carried out independently and a broad spectrum of pathology and 'healthy' controls examined." These conditions were fulfilled in the present study. The ultrasonic diagnosis was obtained before liver biopsy in all patients. In the 24 controls, liver biopsy was normal and visualisation of the liver at surgery or peritoneoscopy in 21 subjects revealed no abnormality. Among the 80 patients, less than 10% had signs of severe liver disease such as ascites, a low serum albumin, or a prothrombim time less than 50 %. In the 36 alcoholic patients (defined as consuming more than 80 g of ethanol/day for more than five years), the final diagnosis was: normal liver in four, steatosis in nine, steatosis and/or fibrosis in eight, hepatitis in three, cirrhosis in 12. We therefore consider that we have included adequate controls and a wide spectrum of liver pathology to enable evaluation of ultrasound as a diagnostic tool in liver disease.
All controls had a normal ultrasonogram. Thus, the specificity was 100 %, as no control had an abnormal test (no false positive), and the predictive value of a positive test was 100 %, as all patients with an abnormal ultrasonogram had liver disease. In two retrospective evaluations of ultrasonography in hepatocellular disease, a false positive rate of respectively 0% and 24% was obtained. 
